Key figures

Strong 2013 performance paves the way for future growth

  • Healthy order intake growth in demanding markets
  • EBITDA margin of 17.1 % and EBIT margin of 12.7 %
  • Oerlikon’s position amongst leading industrial peers confirmed
  • Result from continuing operations increased by 18.8 % to CHF 259 million
  • Further improved net liquidity of CHF 981 million and equity ratio of 51 %
  • Second consecutive dividend increase of 8 % to CHF 0.27 per share recommended
  • Acquisition of Sulzer Metco will form global technology leader for Surface Solutions
  • Outlook 2014: sales growth, stable order intake and stable profitability

Five-year summary of key figures

in CHF million 2013 2012 2011 2010  2009

Order intake1

2 893 2 802 2 878 4 520 2 996
Order backlog1 825 834 971 1 702 997
Sales1 2 883 2 906 2 731 3 601 2 877
           
EBITDA1 492 547 450 278 -165
– as % of sales 17 % 19 % 16 % 8 % -6 %
EBIT1 366 421 318 51 -589
– as % of sales 13 % 14 % 12 % 1 % -20 %
           
Net profit/loss2 201 380 224 5 -592
– as % of equity attributable to shareholders of the parent 10 % 20 % 14 % 0 % -120 %
           
Cash flow from operating activities3 435 414 544 354 -92
Capital expenditure for property, plant and equipment
and intangible assets1
180 181 167 150 130
           
Total assets 4 094 4 158 4 573 4 475 4 342
Equity attributable to shareholders of the parent2 2 072 1 860 1 586 1 430 493
– as % of total assets 51 % 45 % 35 % 32 % 11 %
           
Net cash4 981 339 -86 -274 -1 646
           
Net Operating assets5 1 586 1 575 2 205 2 196 2 821
Number of employees1 12 860 12 708 12 726 16 657 16 369
Personnel expenses1 766 765 740 1 015 1 001
Research and development expenditures1,6 122 106 102 239 210

1 Continuing operations.
2 2012 restated.
3 Before changes in net current assets.
4 Net cash includes cash and cash equivalents and marketable securities less current and non-current debt.
5 Net operating assets include current and non current operating assets (including goodwill and brands and exclunding cash and cash equivalents, financial assets, current and deferred tax receivables) less operating liabilities (excluding financial liabilities, current and deferred tax payables).
6 Research and development expenditure includes expenses recognized as intangible assets.